Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

for
Solid Tumors, Lymphoma
Location: Cleveland OH
Sponsor: Spectrum Pharmaceuticals, Inc

Sex: All

Age: 0 - 17

Code: NCT04570423

Phase 2, Recruiting

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

for
Ovarian Cancer, Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Fairfax VA,
Sponsor: OnCusp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06234423

Phase 1, Recruiting

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

for
Endometrioid Cancer, Mucinous Ovarian Cancer,
Location: Orlando FL, New Orleans LA, Oklahoma City OK,
Sponsor: University of Oklahoma

Sex: Female

Age: 18 - 70+

Code: NCT05512208

Phase 2, Recruiting

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

for
Solid Tumor, Lymphoma
Location: Morristown NJ, Chicago IL
Sponsor: MultiVir, Inc.

Sex: All

Age: 18+

Code: NCT03544723

Phase 2, Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

for
Solid Tumors, Sarcoma
Location: Boston MA, New York NY, Nashville TN
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644755

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06246955

Recruiting

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

for
Pediatric Cancer
Location: Hartford CT, Miami FL, Buffalo NY, Tampa FL,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 0+

Code: NCT06423950

Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Philadelphia PA, Fairfax VA, Durham NC, Orlando FL,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06108050

Phase 1, Recruiting

Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

for
Diagnosis of Cancer of Various Organs
Location: San Diego CA
Sponsor: ClearNote Health

Sex: All

Age: 21 - 70+

Code: NCT03869814

Recruiting

Study of APR-1051 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Brunswick NJ, Fairfax VA, Cleveland OH, Houston TX,
Sponsor: Aprea Therapeutics

Sex: All

Age: 18+

Code: NCT06260514

Phase 1, Recruiting

A Study of JNJ-87890387 for Advanced Solid Tumors

for
Neoplasms, Advanced Solid Tumors
Location: Grand Rapids MI, Nashville TN
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06178614

Phase 1, Recruiting

Role of Gut Microbiome in Cancer Therapy

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT05112614

Recruiting

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Irving TX, Austin TX,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06804824

Phase 1, Recruiting

Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors

for
Neoplasms, Chronic Disease
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT05391217

Recruiting

The Effects of the CF Carrier State on the Kidneys and Pancreas

for
Carrier State, Pancreatic Disease, Kidney Diseases
Location: Iowa City IA
Sponsor: Philip Polgreen

Sex: All

Age: 18 - 70+

Code: NCT05474417

Recruiting

5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

for
Neoplasms, Solid Tumors
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT03366116

Phase 1, Recruiting

Radiotherapy Patient Education With Virtual Reality

for
Anxiety, Cancer
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06506435

Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for
Breast Cancer, Solid Tumors, Adult
Location: Boston MA, New York NY, Fairfax VA, Tampa FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05768139

Phase 1, Phase 2, Recruiting

Personalized Models for Cancer Research

for
Solid Tumor, Adult
Location: New York NY
Sponsor: New York Stem Cell Foundation Research Institute

Sex: All

Age: 18+

Code: NCT06350539

Recruiting

IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

for
Cancer
Location: Philadelphia PA
Sponsor: State University of New York at Buffalo

Sex: All

Age: 18+

Code: NCT06206941

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial